IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TABELLINI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.356
EU - Europa 2.562
AS - Asia 1.393
OC - Oceania 7
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
Totale 8.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.343
CN - Cina 1.036
PL - Polonia 934
UA - Ucraina 546
FR - Francia 323
DE - Germania 209
IT - Italia 209
HK - Hong Kong 164
FI - Finlandia 107
IE - Irlanda 87
GB - Regno Unito 82
IN - India 78
SE - Svezia 37
SG - Singapore 32
VN - Vietnam 25
KR - Corea 22
TR - Turchia 21
CA - Canada 13
BE - Belgio 11
AU - Australia 7
NL - Olanda 7
EU - Europa 6
IR - Iran 6
MU - Mauritius 4
RU - Federazione Russa 3
CL - Cile 2
IM - Isola di Man 2
JP - Giappone 2
RO - Romania 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 8.333
Salva come PNG Salva come JPEG
Città #
Warsaw 933
Fairfield 722
Woodbridge 552
Houston 432
Shenzhen 403
Jacksonville 394
Ashburn 315
Cambridge 274
Seattle 268
Wilmington 264
Ann Arbor 245
Princeton 166
Hong Kong 163
Brescia 140
Beijing 135
Chandler 133
Nanjing 118
New York 111
Dublin 85
Dearborn 79
Nanchang 69
Shenyang 46
Helsinki 40
San Diego 36
Des Moines 34
Changsha 32
Hebei 32
Jinan 31
Dong Ket 24
Tianjin 24
Jiaxing 20
Seongnam 19
Taizhou 19
London 18
Milan 18
Ningbo 18
San Francisco 17
Kunming 14
Singapore 14
Kocaeli 13
Toronto 12
Hangzhou 10
Shanghai 10
Verona 10
Zhengzhou 10
Augusta 8
Brussels 8
Haikou 8
Lancaster 7
Phoenix 7
Sydney 6
Leawood 5
Mcallen 5
Monmouth Junction 5
Norwalk 5
Ardabil 4
Chiswick 4
Guangzhou 4
Lanzhou 4
Washington 4
Boardman 3
Kilburn 3
Orange 3
Taiyuan 3
Aberdare 2
Acton 2
Amsterdam 2
Baotou 2
Charlotte 2
Chicago 2
Cluj-Napoca 2
Douglas 2
Frankfurt am Main 2
Lappeenranta 2
Los Angeles 2
Lumezzane 2
Marcheno 2
Oklahoma City 2
Olginate 2
Redmond 2
Riyadh 2
San Benedetto Po 2
San Mateo 2
Seoul 2
Vobarno 2
Waanrode 2
Bandar Seri Begawan 1
Bangkok 1
Brooklyn 1
Canberra 1
Carpinone 1
Casoria 1
Castenedolo 1
Centurion 1
Changchun 1
Edinburgh 1
Fiumicino 1
Fremont 1
Glendale 1
Gravedona 1
Totale 6.676
Salva come PNG Salva come JPEG
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 513
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 284
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 280
NFKB1 regulates human NK cell maturation and effector functions 273
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 243
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 238
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 230
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 207
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 150
The RAC2-PI3K axis regulates human NK cell maturation and function 149
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 136
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 129
CTLA-4 regulates human Natural Killer cell effector functions 129
Inherited DOCK2 deficiency in patients with early-onset invasive infections 122
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 120
Effects of opioid therapy on human natural killer cells. 117
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 111
Rab3A and Rab3D control the total granule number and the fraction of granules docked at the plasma membrane in PC12 cells 109
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 108
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels 105
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 105
Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study 102
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. 101
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix. 100
Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways 100
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling 100
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 99
Re-examination of the mechanisms regulating nuclear inositol lipid metabolism. 98
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 98
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 98
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. 96
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 96
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. 95
Flow cytometric detection of total and serine 473 phosphorylated Akt. 95
Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 94
A threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. 94
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy. 93
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. 89
The emerging multiple roles of nuclear Akt 89
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway. 89
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 88
Nuclear apoptotic changes: an overview 88
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 88
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. 87
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 87
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation 85
Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study 84
Localization of the small monomeric GTPases Rab3D and Rab3A in the AtT-20 rat pituitary cell line. 82
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 81
Nuclear changes in necrotic HL-60 cells. 80
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 79
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 78
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 77
Nuclear lipids: new functions for old molecules? 76
The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells. 75
Further considerations on the intranuclear distribution of HMGI/Y proteins. 73
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 69
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: Involvement of FOXO3a. 67
P85α is an intrinsic regulator of human natural killer cell effector functions 66
Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by {alpha}-actinin. 64
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 64
Phosphoinositide-specific phospholipase Cbeta1 expression is not linked to nerve growth factor-induced differentiation, cell survival or cell cycle control in PC12 rat pheocromocytoma cells. 63
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. 62
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 61
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 61
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 57
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 56
The controversial nuclear matrix: a balanced point of view. 55
Molecular characterization of protein kinase C-alpha binding to lamin A. 54
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 52
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1 52
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. 51
Nuclear expression of diacylgycerol kinases: possibile involvement in DNA replication 51
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 51
Insulin-like growth factor-I-dependent stimulation of nuclear phospholipase C-beta1 activity in Swiss 3T3 cells requires an intact cytoskeleton and is paralleled by increased phosphorylation of the phospholipase. 49
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 49
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 47
Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. 45
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. 44
Natural killer cell impairment in ovarian clear cell carcinoma 44
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 41
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 31
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 31
Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party 30
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 30
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 20
FGF-trapping hampers cancer stem-like cells in uveal melanoma 7
Totale 8.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019441 0 0 0 0 0 0 0 0 0 0 232 209
2019/20202.555 350 115 151 256 167 280 252 272 182 306 96 128
2020/20211.437 32 141 31 259 63 138 69 146 200 130 168 60
2021/2022827 61 158 21 56 15 32 38 50 34 97 66 199
2022/2023519 125 1 3 31 33 146 5 52 59 1 28 35
2023/2024910 36 11 462 27 17 130 32 25 163 2 5 0
Totale 8.516